The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Menomune-A & C & Y & W-135 Market Research Report 2025
Synopsis
Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
The global Menomune-A & C & Y & W-135 market was valued at US$ 1354 million in 2023 and is anticipated to reach US$ 1802.2 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Menomune-A & C & Y & W-135, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menomune-A & C & Y & W-135.
Report Scope
The Menomune-A & C & Y & W-135 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Menomune-A & C & Y & W-135 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Menomune-A & C & Y & W-135 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Hualan Bio
Beijing Luzhu Biopharmaceutical
Walvax
Kanghua Bio
Segment by Type
Oligosaccharide
Polysaccharide
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Menomune-A & C & Y & W-135 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Menomune-A & C & Y & W-135 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Menomune® – A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
The global Menomune-A & C & Y & W-135 market was valued at US$ 1354 million in 2023 and is anticipated to reach US$ 1802.2 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Menomune-A & C & Y & W-135, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Menomune-A & C & Y & W-135.
Report Scope
The Menomune-A & C & Y & W-135 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Menomune-A & C & Y & W-135 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Menomune-A & C & Y & W-135 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Hualan Bio
Beijing Luzhu Biopharmaceutical
Walvax
Kanghua Bio
Segment by Type
Oligosaccharide
Polysaccharide
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Menomune-A & C & Y & W-135 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Menomune-A & C & Y & W-135 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Menomune-A & C & Y & W-135 Market Overview
1.1 Product Overview and Scope of Menomune-A & C & Y & W-135
1.2 Menomune-A & C & Y & W-135 Segment by Type
1.2.1 Global Menomune-A & C & Y & W-135 Market Value Comparison by Type (2024-2030)
1.2.2 Oligosaccharide
1.2.3 Polysaccharide
1.3 Menomune-A & C & Y & W-135 Segment by Application
1.3.1 Global Menomune-A & C & Y & W-135 Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Menomune-A & C & Y & W-135 Market Size Estimates and Forecasts
1.4.1 Global Menomune-A & C & Y & W-135 Revenue 2019-2030
1.4.2 Global Menomune-A & C & Y & W-135 Sales 2019-2030
1.4.3 Global Menomune-A & C & Y & W-135 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Menomune-A & C & Y & W-135 Market Competition by Manufacturers
2.1 Global Menomune-A & C & Y & W-135 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Menomune-A & C & Y & W-135 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Menomune-A & C & Y & W-135 Average Price by Manufacturers (2019-2024)
2.4 Global Menomune-A & C & Y & W-135 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Menomune-A & C & Y & W-135, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Menomune-A & C & Y & W-135, Product Type & Application
2.7 Menomune-A & C & Y & W-135 Market Competitive Situation and Trends
2.7.1 Menomune-A & C & Y & W-135 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Menomune-A & C & Y & W-135 Players Market Share by Revenue
2.7.3 Global Menomune-A & C & Y & W-135 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Menomune-A & C & Y & W-135 Retrospective Market Scenario by Region
3.1 Global Menomune-A & C & Y & W-135 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Menomune-A & C & Y & W-135 Global Menomune-A & C & Y & W-135 Sales by Region: 2019-2030
3.2.1 Global Menomune-A & C & Y & W-135 Sales by Region: 2019-2024
3.2.2 Global Menomune-A & C & Y & W-135 Sales by Region: 2025-2030
3.3 Global Menomune-A & C & Y & W-135 Global Menomune-A & C & Y & W-135 Revenue by Region: 2019-2030
3.3.1 Global Menomune-A & C & Y & W-135 Revenue by Region: 2019-2024
3.3.2 Global Menomune-A & C & Y & W-135 Revenue by Region: 2025-2030
3.4 North America Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.4.1 North America Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.4.3 North America Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.5.1 Europe Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.5.3 Europe Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.6.1 Asia Pacific Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.6.3 Asia Pacific Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.7.1 Latin America Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.7.3 Latin America Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Menomune-A & C & Y & W-135 Market Facts & Figures by Country
3.8.1 Middle East and Africa Menomune-A & C & Y & W-135 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Menomune-A & C & Y & W-135 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Menomune-A & C & Y & W-135 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Menomune-A & C & Y & W-135 Sales by Type (2019-2030)
4.1.1 Global Menomune-A & C & Y & W-135 Sales by Type (2019-2024)
4.1.2 Global Menomune-A & C & Y & W-135 Sales by Type (2025-2030)
4.1.3 Global Menomune-A & C & Y & W-135 Sales Market Share by Type (2019-2030)
4.2 Global Menomune-A & C & Y & W-135 Revenue by Type (2019-2030)
4.2.1 Global Menomune-A & C & Y & W-135 Revenue by Type (2019-2024)
4.2.2 Global Menomune-A & C & Y & W-135 Revenue by Type (2025-2030)
4.2.3 Global Menomune-A & C & Y & W-135 Revenue Market Share by Type (2019-2030)
4.3 Global Menomune-A & C & Y & W-135 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Menomune-A & C & Y & W-135 Sales by Application (2019-2030)
5.1.1 Global Menomune-A & C & Y & W-135 Sales by Application (2019-2024)
5.1.2 Global Menomune-A & C & Y & W-135 Sales by Application (2025-2030)
5.1.3 Global Menomune-A & C & Y & W-135 Sales Market Share by Application (2019-2030)
5.2 Global Menomune-A & C & Y & W-135 Revenue by Application (2019-2030)
5.2.1 Global Menomune-A & C & Y & W-135 Revenue by Application (2019-2024)
5.2.2 Global Menomune-A & C & Y & W-135 Revenue by Application (2025-2030)
5.2.3 Global Menomune-A & C & Y & W-135 Revenue Market Share by Application (2019-2030)
5.3 Global Menomune-A & C & Y & W-135 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur Menomune-A & C & Y & W-135 Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Menomune-A & C & Y & W-135 Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Hualan Bio
6.3.1 Hualan Bio Corporation Information
6.3.2 Hualan Bio Description and Business Overview
6.3.3 Hualan Bio Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hualan Bio Menomune-A & C & Y & W-135 Product Portfolio
6.3.5 Hualan Bio Recent Developments/Updates
6.4 Beijing Luzhu Biopharmaceutical
6.4.1 Beijing Luzhu Biopharmaceutical Corporation Information
6.4.2 Beijing Luzhu Biopharmaceutical Description and Business Overview
6.4.3 Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Luzhu Biopharmaceutical Menomune-A & C & Y & W-135 Product Portfolio
6.4.5 Beijing Luzhu Biopharmaceutical Recent Developments/Updates
6.5 Walvax
6.5.1 Walvax Corporation Information
6.5.2 Walvax Description and Business Overview
6.5.3 Walvax Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Menomune-A & C & Y & W-135 Product Portfolio
6.5.5 Walvax Recent Developments/Updates
6.6 Kanghua Bio
6.6.1 Kanghua Bio Corporation Information
6.6.2 Kanghua Bio Description and Business Overview
6.6.3 Kanghua Bio Menomune-A & C & Y & W-135 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kanghua Bio Menomune-A & C & Y & W-135 Product Portfolio
6.6.5 Kanghua Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Menomune-A & C & Y & W-135 Industry Chain Analysis
7.2 Menomune-A & C & Y & W-135 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Menomune-A & C & Y & W-135 Production Mode & Process
7.4 Menomune-A & C & Y & W-135 Sales and Marketing
7.4.1 Menomune-A & C & Y & W-135 Sales Channels
7.4.2 Menomune-A & C & Y & W-135 Distributors
7.5 Menomune-A & C & Y & W-135 Customers
8 Menomune-A & C & Y & W-135 Market Dynamics
8.1 Menomune-A & C & Y & W-135 Industry Trends
8.2 Menomune-A & C & Y & W-135 Market Drivers
8.3 Menomune-A & C & Y & W-135 Market Challenges
8.4 Menomune-A & C & Y & W-135 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
